+ Watch ALKS
on My Watchlist
A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.
Very high profit marginVery low P/EVery high forward P/EEarnings expected to grow at a rate of 42% over the next 5 years.Very little debt (LT Debt/Equity is .12)I put this stock at $30-40 by sometime next year. (Brave I know)Enjoy!DH
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions